PT99791A - Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem - Google Patents

Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem

Info

Publication number
PT99791A
PT99791A PT99791A PT9979191A PT99791A PT 99791 A PT99791 A PT 99791A PT 99791 A PT99791 A PT 99791A PT 9979191 A PT9979191 A PT 9979191A PT 99791 A PT99791 A PT 99791A
Authority
PT
Portugal
Prior art keywords
hiv
contain
preparation
gas
pharmaceutical compositions
Prior art date
Application number
PT99791A
Other languages
English (en)
Other versions
PT99791B (pt
Inventor
Matthias Niedrig
Susanne Modrow
Maus Wolf
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT99791A publication Critical patent/PT99791A/pt
Publication of PT99791B publication Critical patent/PT99791B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT99791A 1990-12-14 1991-12-13 Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem PT99791B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039925A DE4039925A1 (de) 1990-12-14 1990-12-14 Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT99791A true PT99791A (pt) 1992-12-31
PT99791B PT99791B (pt) 1999-05-31

Family

ID=6420301

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99791A PT99791B (pt) 1990-12-14 1991-12-13 Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem

Country Status (12)

Country Link
US (1) US5612453A (pt)
EP (2) EP0490383B1 (pt)
JP (2) JP3369585B2 (pt)
KR (1) KR920012114A (pt)
AT (2) ATE143974T1 (pt)
AU (1) AU661464B2 (pt)
CA (1) CA2057612C (pt)
DE (3) DE4039925A1 (pt)
DK (2) DK0490383T3 (pt)
ES (2) ES2176363T3 (pt)
IE (1) IE914353A1 (pt)
PT (1) PT99791B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA903492B (en) * 1989-05-15 1991-02-27 Akzo Nv T-lymphotropic retrovirus monoclonal antibodies
US6426412B1 (en) * 1995-12-20 2002-07-30 Subsidiary No. 3, Inc. Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
NO314588B1 (no) * 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
EP1855112A1 (en) * 2006-05-10 2007-11-14 Inserm Method for the in vitro screening of compounds inhibiting production of infectious HIV-1 virions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3672624D1 (de) * 1985-02-05 1990-08-23 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
EP0356007A3 (en) * 1988-07-22 1991-07-03 Medical Research Council Antigenic determinants
FR2640877A1 (pt) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
ATE135113T1 (de) * 1988-12-20 1996-03-15 Clarity Technologies Inc Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen
GB8910145D0 (en) * 1989-05-03 1989-06-21 Connaught Lab Synthetic peptides for an hiv-1 vaccine
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
EP0510054A1 (en) * 1990-01-05 1992-10-28 United Biomedical, Inc. Hiv-1 core protein fragments
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov

Also Published As

Publication number Publication date
DE59108261D1 (de) 1996-11-14
AU8976691A (en) 1992-06-18
DK0732339T3 (da) 2002-08-19
DK0490383T3 (da) 1997-02-17
EP0732339A1 (de) 1996-09-18
ATE216706T1 (de) 2002-05-15
KR920012114A (ko) 1992-07-25
PT99791B (pt) 1999-05-31
EP0490383A2 (de) 1992-06-17
DE4039925A1 (de) 1992-06-17
EP0490383B1 (de) 1996-10-09
EP0732339B1 (de) 2002-04-24
US5612453A (en) 1997-03-18
ES2176363T3 (es) 2002-12-01
DE59109235D1 (de) 2002-05-29
ATE143974T1 (de) 1996-10-15
JP3369585B2 (ja) 2003-01-20
JP2003176299A (ja) 2003-06-24
EP0490383A3 (en) 1993-06-30
AU661464B2 (en) 1995-07-27
IE914353A1 (en) 1992-06-17
ES2095899T3 (es) 1997-03-01
CA2057612A1 (en) 1992-06-15
CA2057612C (en) 2002-02-05
JPH06107697A (ja) 1994-04-19

Similar Documents

Publication Publication Date Title
ATE92502T1 (de) Huellenantigene vom menschlichen immunodefizienz- virus und deren verwendungen.
EP0339504A3 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FI932561A7 (fi) Proteiinit, joilla on muuttuneet epitoopit ja menetelmiä niiden valmistamiseksi
ATE154610T1 (de) Synthetische vom hiv-gp120-env-protein abgeleitete peptide und ihre anwendung
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
NO973250L (no) Preparater for avlevering av antigener
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
ZA936970B (en) Anti-feline immunodeficiency virus (FIV) vaccines
DK0491628T3 (da) Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
PT99791A (pt) Processo para a preparacao de peptidos seleccionados do antigene especifico de grupo (gas) do virus da imunodeficiencia humana (hiv) e de composicoes farmaceu-ticas que os contem
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DK0426314T3 (da) HIV-relaterede peptider
PT90218A (pt) Processo para a preparacao de anticorpos monoclonais humanos que reconhecem especificamente celulas do virus da hidrofobia, celulas que os produzem e preparacoes que os contem
NO902491D0 (no) Proteiner, vaksiner og nukleinsyrer.
DE3485972D1 (de) Antigen aktive aminosaeuresequenzen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19921027

FG3A Patent granted, date of granting

Effective date: 19990222

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000831